Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stinchcombe

Showing results (501-510 of 575) with videos related to

Pageof 58
Sort By:
Cancer|October 22, 2018
A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patientsThomas E Stinchcombe, Wen Fan, Steven E Schild, et al.
The Oncologist|February 12, 2017
Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) TrialsXiaofei Wang, Xiaoyi Wang, Lydia Hodgson, et al.
American Journal of Clinical Oncology|March 25, 2015
ACR Appropriateness Criteria(®) induction and adjuvant therapy for N2 non-small-cell lung cancerHenning Willers, Thomas E Stinchcombe, R Bryan Barriger, et al.
Journal of Medical Genetics|July 11, 2006
Novel Munc13-4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosisA Santoro, S Cannella, G Bossi, et al.
Oncology (Williston Park, N.Y.)|August 21, 2014
ACR Appropriateness Criteria® nonsurgical treatment for locally advanced non-small-cell lung cancer: good performance status/definitive intentJoe Yujiao Chang, Larry L Kestin, R Bryan Barriger, et al.
Regulatory Toxicology and Pharmacology : RTP|December 11, 2023
Retrospective evaluation of the eye irritation potential of agrochemical formulationsNeepa Choksi, Andreia Latorre, Shadia Catalano, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 21, 2024
Corrigendum to: Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance)" [The Journal of Thoracic and Cardiovascular Surgery Volume 167, Issue 1, January 2024, Pages 338-347.e1]Nasser Altorki, Xiaofei Wang, Bryce Damman, et al.
Cancer|January 17, 2020
Nab-paclitaxel in older patients with non-small cell lung cancer who have developed disease progression after platinum-based doublet chemotherapyJared M Weiss, Nathan Pennell, Allison M Deal, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 20, 2023
Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance)Nasser Altorki, Xiaofei Wang, Bryce Damman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2024
Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung CancerThomas E Stinchcombe, Xiaofei Wang, Bryce Damman, et al.
Pageof 58

Showing results (501-510 of 575) with videos related to

Sort By:
Pageof 58
Cancer|October 22, 2018
A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patientsThomas E Stinchcombe, Wen Fan, Steven E Schild, et al.
The Oncologist|February 12, 2017
Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) TrialsXiaofei Wang, Xiaoyi Wang, Lydia Hodgson, et al.
American Journal of Clinical Oncology|March 25, 2015
ACR Appropriateness Criteria(®) induction and adjuvant therapy for N2 non-small-cell lung cancerHenning Willers, Thomas E Stinchcombe, R Bryan Barriger, et al.
Journal of Medical Genetics|July 11, 2006
Novel Munc13-4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosisA Santoro, S Cannella, G Bossi, et al.
Oncology (Williston Park, N.Y.)|August 21, 2014
ACR Appropriateness Criteria® nonsurgical treatment for locally advanced non-small-cell lung cancer: good performance status/definitive intentJoe Yujiao Chang, Larry L Kestin, R Bryan Barriger, et al.
Regulatory Toxicology and Pharmacology : RTP|December 11, 2023
Retrospective evaluation of the eye irritation potential of agrochemical formulationsNeepa Choksi, Andreia Latorre, Shadia Catalano, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 21, 2024
Corrigendum to: Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance)" [The Journal of Thoracic and Cardiovascular Surgery Volume 167, Issue 1, January 2024, Pages 338-347.e1]Nasser Altorki, Xiaofei Wang, Bryce Damman, et al.
Cancer|January 17, 2020
Nab-paclitaxel in older patients with non-small cell lung cancer who have developed disease progression after platinum-based doublet chemotherapyJared M Weiss, Nathan Pennell, Allison M Deal, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 20, 2023
Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance)Nasser Altorki, Xiaofei Wang, Bryce Damman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2024
Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung CancerThomas E Stinchcombe, Xiaofei Wang, Bryce Damman, et al.
Pageof 58